The World Health Organization (WHO) is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries, and monitoring and assessing health trends. CBER has worked with WHO in the global community to improve human public health worldwide for many years. Strengthening regulatory capacity is integral to ensuring global access to safe and effective vaccines and other biological products.
CBER has awarded Cooperative Agreements to WHO to provide funding support and scientific guidance to advance projects of mutual interest. Activities supported by the Cooperative Agreements have included assessments of regulatory authorities, training workshops, development of WHO Guideline documents, collaborative studies that support standards development, activities to build pharmacovigilance capacity in low and middle income countries, and other regulatory capacity building projects. The Cooperative Agreements are responsive to global needs and CBER priorities, and are a means to provide support to further advance FDA’s goal of strengthening regulatory systems worldwide.